Skip to main content

ScienceDex / Researcher record

Cherry, Sara

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #11,481
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

$912.1K
Full award amounts, FY2023
2
Records listing this PI
#11,481
By linked amount among FY2023 PIs
2007
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2007$380,5301#18,009
2008$372,9101#18,209
2009$580,5151#15,218
2010$368,3761#23,292
2011$364,2761#21,025
2012$878,3232#8,110
2013$834,5873#8,025
2014$1,121,7044#5,914
2015$1,565,8034#3,908
2016$1,207,2133#5,466
2017$1,054,0703#6,483
2018$1,185,8353#6,039
2019$1,754,6004#3,815
2020$1,252,7093#1,981
2021$3,139,2067#1,582
2022$1,994,2325#3,647
2023$912,1112#11,481

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20071 record
  2. FY20081 record
  3. FY20091 record
  4. FY20101 record
  5. FY20111 record
  6. FY20122 records
  7. FY20133 records
  8. FY20144 records
  9. FY20154 records
  10. FY20163 records
  11. FY20173 records
  12. FY20183 records
  13. FY20194 records
  14. FY20203 records
  15. FY20217 records
  16. FY20225 records
  17. FY2023 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Cherry, Sara. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2027 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award categories

  • Pathology

FY2023 award records by amount

NIH award records listing Cherry, Sara as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI150246-05R01Contact PI
    The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
    University of Pennsylvania · Pathology (NIH department code)
    $505.9K
    award amount
  • 5R01AI152362-04R01Contact PI
    Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
    University of Pennsylvania · Pathology (NIH department code)
    $406.3K
    award amount

Award organization

Organizations that administered FY2023 awards listing Cherry, Sara as a PI.

FY2023 award administered by University of Pennsylvania (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2007
    First NIH Award
    University of Pennsylvania
  2. 2008
    $500K Cumulative Funding
  3. 2009
    $1M Cumulative Funding
  4. 2011
    $2M Cumulative Funding
  5. 2012
    Entered Top 50% Nationally
    Ranked #8110
  6. 2012
    R01 Grant Holder
  7. 2015
    $5M Cumulative Funding
  8. 2015
    Entered Top 25% Nationally
    Ranked #3908
  9. 2019
    $10M Cumulative Funding
  10. 2020
    Entered Top 10% Nationally
    Ranked #1981